References: JIA-associated uveitis

  • Cann M, Ramanan AV, Crawford A, Dick AD, Clarke SLN, Rashed F, et al. Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy. Pediatric Rheumatology 2018;16(1):51. https://www.ncbi.nlm.nih.gov/pubmed/30081917
  • Ghoraba HH, Matsumiya W, Khojasteh H, Akhavanrezayat A, Karaca I, Or C, et al. Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis. Clinical Opthamology 2022;16:1697-706. https://www.ncbi.nlm.nih.gov/pubmed/35673349
  • Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. American Journal of Ophthalmology 2005;140(3):509-16. https://www.ncbi.nlm.nih.gov/pubmed/16196117
  • Renton WD, Jung J, Palestine AG. Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis-associated uveitis. Cochrane Database of Systematic Review 2022;10(10):CD013818. https://www.ncbi.nlm.nih.gov/pubmed/36239193
  • Smith JR, Matthews JM, Conrad D, Hall AJ, Niederer RL, Singh-Grewal D, et al. Recommendations for the management of childhood juvenile idiopathic arthritis-type chronic anterior uveitis. Clinical and Experimental Opthamology 2021;49(1):38-45. https://www.ncbi.nlm.nih.gov/pubmed/33426782
  • Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Juvenile Idiopathic Arthritis-Associated Chronic Anterior Uveitis. American Journal of Ophthalmology 2021;228:192-7. https://www.ncbi.nlm.nih.gov/pubmed/33845021